Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Double-blinded, Randomized Placebo-controlled Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3

NCT03746587 is registered in ClinicalTrials.gov with ZevraDenmark as lead sponsor.

NCT NCT03746587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03746587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Double-blinded, Randomized Placebo-controlled Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3
Lead sponsor
ZevraDenmark
Phase
Phase 2
Overall status
Terminated
Start date
June 6, 2018
Completion date
October 15, 2021
Enrollment
39 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher disease, type 1, gaucher disease, type 3